Therapeutic Peptides: A New Frontier for Orthopaedic Repair and Regeneration

Orthopaedic conditions, ranging from fractures and cartilage damage to tendon injuries and osteoarthritis, represent a significant global health burden, often leading to chronic pain and disability. Current treatments frequently involve invasive surgeries or symptomatic relief, which may not address the underlying tissue degeneration or promote robust healing. This review addresses the critical need for novel, biologically active therapies by exploring the potential of therapeutic peptides to revolutionize orthopaedic care.

The review identified multiple classes of peptides demonstrating significant promise across various orthopaedic conditions. For instance, peptides like BPC-157 (a synthetic peptide known for its regenerative properties) were highlighted for their regenerative potential in tendon and ligament injuries, while PTHrP analogs (parathyroid hormone-related protein analogs) showed efficacy in promoting bone formation and fracture healing. The authors noted that peptides targeting inflammation and pain modulation, such as those interacting with opioid receptors, also represent a significant area of development. Many peptides exhibit superior specificity and reduced off-target effects compared to traditional small molecule drugs, offering a compelling alternative for chronic and difficult-to-treat conditions. The most critical finding is the broad and diverse therapeutic potential of peptides to address complex orthopaedic pathologies, from tissue regeneration and cartilage repair to inflammation control and pain management.